Hormone Receptor Negative Tumor clinical trials at UCSF
1 research study open to eligible people
A hormone receptor negative tumor lacks receptors for hormones that typically influence cancer growth. UCSF is exploring new breast cancer treatments through trials that focus on personalized drug therapies. These studies are part of efforts to advance cancer treatment using adaptive strategies.
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
open to eligible people ages 18 years and up
The purpose of this study is to further advance the ability to practice personalized medicine by learning which new drug agents are most effective with which types of breast cancer tumors and by learning more about which early indicators of response (tumor analysis prior to surgery via magnetic resonance imaging (MRI) images along with tissue and blood samples) are predictors of treatment success.
San Francisco, California and other locations
Last updated: